Reaction
Multiple Sclerosis Pseudo Relapse reporting signals
As of the last recalculation, Multiple Sclerosis Pseudo Relapse appears in 326 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is OFATUMUMAB (PRR 164.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ofatumumab | 68 | 164.8 | 165.2 |
| Cladribine | 17 | 119.1 | 119.3 |
| Ocrelizumab | 82 | 112.5 | 112.6 |
| Siponimod | 13 | 96.9 | 97.0 |
| Diroximel Fumarate | 17 | 96.0 | 96.2 |
| Natalizumab | 57 | 24.1 | 24.1 |
| Teriflunomide | 15 | 22.2 | 22.2 |
| Dalfampridine | 22 | 20.9 | 20.9 |